{"text_format":"1","workbook":"xlsx","n_sheets":1,"sheets":["CF_E"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":0,"defined_names":0,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"CF_E","index":0,"n_rows":48,"n_cols":6,"rows_kept":48,"cut":false,"hidden":false,"merged":[[2,1,2,2]]}
[]
[null,"Consolidated statement of cash flows (IFRS)"]
[null,"from 1 October 2020 to 30 September 2021"]
[null,null,"2019/20\n1 Oct 20 to 30 Sep 21","2019/20\n1 Oct 19 to 30 Sep 20"]
[null,null,"€ k","€ k"]
[null,"Consolidated profit",237519,123421]
[null,"Income taxes",101531,55296]
[null,"Interest income/expenses",7803,26432]
[null,"Result from other investments",-95,0]
[null,"Result from the change in fair value of contingent purchase price obligations",1840,-23131]
[null,"Result from the sale of asstes held for sale",-2447,0]
[null,"Depreciation and amortization",61584,60425]
[null,"Gains/losses on disposal/depreciation of fixed assets",1442,94]
[null,"Interest and dividens received",1376,1428]
[null,"Interest paid",-1629,-1365]
[null,"Income tax payments",-97908,-58964]
[null,"Trade receivables",-62102,54177]
[null,"Inventories",18,-28421]
[null,"Other assets",-5531,-2528]
[null,"Trade payables",52692,-25171]
[null,"Provisions and financial liabilities",54459,-7015]
[null,"Other liabilities",12111,3849]
[null,"Cashflow from operating activities",362663,178527]
[]
[null,"Cash outflow for investments in property, plant and equipment",-30122,-29325]
[null,"Cash outflow for investments in other intangible assets",-35979,-15661]
[null,"Proceeds from disposal of fixed assets",403,128]
[null,"Proceeds from disposal of financial assets",0,163]
[null,"Cash outflow for investments in financial assets",-2416,-25]
[null,"Purchase of shares in affiliated consolidated companies, net of cash acquired*",-11509,-26227]
[null,"Proceeds from the sale of assets held for sale",4423,0]
[null,"Cashflow from investing activities*",-75200,-70947]
[]
[null,"Change in current loans",420,27]
[null,"Change in treasury receivables",-241624,-50329]
[null,"Change in treasury payables",14950,1554]
[null,"Cash receipts from sale-and-leaseback transactions",3977,0]
[null,"Repayment of leasing liabilities",-17727,-16077,null,"incl sale of subsidiary Hexavision"]
[null,"Dividend payment to shareholders of Carl Zeiss Meditec AG",-44720,-58136]
[null,"Dividend payment to non-controlling interests",-1165,0]
[null,"Cashflow from financing activities",-285889,-122961]
[]
[null,"Effect of exchange rate fluctuation on cash and cash equivalents",-337,-1056]
[null,"Change in cash and cash equivalents*",1237,-16437]
[null,"Cash and cash equivalents, beginning of reporting period",6202,22639]
[null,"Cash and cash equivalents, end of reporting period*",7439,6202]
[]
[null,"The following notes are an integral part of the audited consolidated financial statements."]